Prospects for U.S.-China Collaboration in Health Care

President Biden has noted that future U.S. policy towards China  will be governed by the three principles of compete, confront, and collaborate. The media today is filled with examples of competition and confrontation, but there is scant information about successful collaborations between the two countries. Although many reporters and scholars cite the major opportunity for the two nations to cooperate to address climate change, fewer voices have raised the opportunities in the health care sector for the U.S. and China to jointly solve global health problems.

In this webinar we will discuss China’s increasing commitment to R&D in the health care space, including the growing development and manufacturing capabilities of its vaccine and pharmaceutical sectors. We will explore how U.S. government and private companies may tap into China’s expanding health sector to develop products and run clinical trials more quickly. We will also examine how COVID-19 has impacted the U.S. and China’s approach to health care and their contributions to global public goods, including vaccines and other pandemic tools. Our panelists will also review how each country is improving future pandemic preparedness as a result of COVID-19, an area of potential collaboration despite growing political differences.

REGISTER HERE

PANELISTS

Steve Davis currently serves as a Senior Advisor to the Bill & Melinda Gates Foundation, and was previously Interim Director of the foundation’s China office. Steve is well known as a leader and strategist for a wide range of private and non-profit organizations. He was CEO of PATH, a global innovation enterprise that works to advance health equity through innovation and partnerships from 2012 to 2020. He has served as the CEO of global digital media firm Corbis, director of social innovation for McKinsey & Company, and interim CEO of the Infectious Disease Research Institute. Earlier in his career, he practiced law at the international law firm of K&L Gates with a focus on intellectual property and Chinese law.

He is a lecturer in social innovation at the Stanford University Graduate School of Business and serves as a Distinguished Fellow with the World Economic Forum. He also co-chairs the WHO’s Digital Health Advisory Group serves on the boards of Philanthropy University and The Trinity Challenge, and sits on the advisory board or consults with a range of institutions and initiatives, including the Rockefeller Foundation, the New York University School of Global Public Health, Challenge Seattle, the International Digital Health & Artificial Intelligence Research Collaborative (I-DAIR), and the World Economic Forum. He is author of “Undercurrents: Channeling Outrage to Spark Practical Activism” (Wiley, 2020).

Steve holds a B.A. from Princeton University, an M.A. in Chinese studies from the University of Washington, and a law degree from Columbia University. He studied at Peking University in the early 1980s.

Dr. Jennifer Bouey is a senior policy researcher, Tang Chair for China Policy Studies, and an epidemiologist at the RAND Corporation. She also serves as the department chair for International Health at Georgetown University and a professor of policy analysis at the Pardee RAND Graduate School. She leads wide-ranged collaborative research initiatives on global health security and health equity. Currently she is working on projects to promote health diplomacy in the COVID-19 era, gender equity in Asia, U.S.-China Track II dialogues on climate and energy, and health access for migrant women in Bangladesh.

Bouey’s work has been quoted in general interest publications such as The New York Times, The Washington Post, The Hill, and The Economist, as well as scholarly journals such as the American Journal of Public Health, Health Affairs, Emerging Infectious Diseases, and BMJ Open.  Bouey has testified multiple times before U.S. Congressional committees on China’s public health, global health, and health care reforms. Her research on migrant health and social determinants of health were funded by NIH, HRSA/HHS, and multiple foundations. Bouey also has been a consultant to the World Bank Group, UNAIDS, USAID, Hong Kong Government AIDS Fund, and other international NGOs. She earned her Ph.D. and M.P.H. in epidemiology from The George Washington University, and her M.D. from Peking University.

Jeff Hall is a Deputy Director at the Bill & Melinda Gates Foundation, where he oversees strategy, planning, and operational management for the China Country Office.  In this role, he leads a cross-functional team in supporting the development and execution of program and advocacy strategies, including operational guidance, internal programmatic and financial alignment, and external investment support.  The foundation’s office in Beijing works on a breadth of issues within China, as well as on many programs related to China’s increasing contributions to global health and development. In addition to his current role, Jeff has previously helped coordinate the foundation’s initial response to the recent COVID pandemic, and spent several years supporting the foundation’s advocacy and communications activities within North America.

Raised outside of Washington DC, Jeff received his BA in Economics from the University of Virginia, and spent nearly 15 years working in public and private sector consulting around the US and across the globe, including the Middle East and South America.

MODERATOR
Kristi Heim is an experienced communications professional with an expertise in international relations, life sciences and global health. A former journalist, she is currently director of communications for a global immuno-oncology company.

She served as executive director and president of the Washington State China Relations Council (WSCRC), from 2014 to 2016. At WSCRC she developed high-level exchanges and partnerships between companies, institutions and governments in health care, environmental sustainability and other areas.

An award-winning journalist for more than 15 years, she has written on business, technology and global health for publications including the Wall Street Journal, the Seattle Times and the San Jose Mercury News. Kristi is a member of the National Committee on United States-China Relations and a board member of WSCRC. She holds a BA in journalism from California State University Fullerton, and an MA in international studies (China) from the University of Washington.

Date

Feb 02 2022
Expired!

Time

1:00 pm - 2:00 pm

Local Time

  • Timezone: America/New_York
  • Date: Feb 02 2022
  • Time: 4:00 pm - 5:00 pm
Category